The document outlines ProFAX's go-to-market strategy for positioning itself in the growing biopharmaceutical market. The biopharmaceutical market is large and growing, but companies are slowed down by the high computational needs of their algorithms. ProFAX aims to accelerate these algorithms using FPGA programmability to improve performance and reduce power consumption. ProFAX will create a prototype and promote its capabilities at international conferences to attract customers in need of hardware acceleration for complex biopharmaceutical modeling.